TuisSNYNF • OTCMKTS
add
Sanofi SA
Vorige sluiting
$95,50
Jaarwisseling
$90,45 - $119,65
Markkapitalisasie
123,64 mjd USD
Gemiddelde volume
797,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
EPA
Marknuus
.INX
0,00%
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(EUR) | Sep. 2024info | J/J-verandering |
---|---|---|
Inkomste | 14,16 mjd | 11,49% |
Bedryfskoste | 5,99 mjd | 11,39% |
Netto inkomste | 2,82 mjd | 11,49% |
Netto winsgrens | 19,88 | -0,05% |
Wins per aandeel | 1,54 | -39,43% |
EBITDA | 4,91 mjd | 15,96% |
Effektiewe belastingkoers | 20,58% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(EUR) | Sep. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 6,80 mjd | -14,99% |
Totale bates | — | — |
Totale aanspreeklikheid | — | — |
Totale ekwiteit | 73,00 mjd | — |
Uitstaande aandele | 1,25 mjd | — |
Prys om te bespreek | 1,64 | — |
Opbrengs op bates | — | — |
Opbrengs op kapitaal | 10,54% | — |
Kontantvloei
Netto kontantverandering
(EUR) | Sep. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 2,82 mjd | 11,49% |
Kontant van bedrywe | — | — |
Kontant van beleggings | — | — |
Kontant van finansiering | — | — |
Netto kontantverandering | — | — |
Beskikbare kontantvloei | — | — |
Meer oor
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in Forbes Global 2000 was 89.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
HUB
Gestig
1973
Hoofkwartier
Webwerf
Werknemers
86 088